Work

Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice

Year: 2010

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-010-1337-6

Authors: Jan H. Beumer, Julie L. Eiseman, Judith A. Gilbert, Julianne L. Holleran, Archibong E. Yellow-Duke, Dana M. Clausen, David Z. D’Argenio, Matthew M. Ames, Pamela A. Hershberger, Robert A. Parise, Lihua Bai, Joseph M. Covey, Merrill J. Egorin

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, Mayo Clinic, University of Southern California, National Cancer Institute

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: G2908934988, Preclinical Pharmacological Studies of Antitumor & Other Therapeutic Agents, G424558205, G5032682418, G741073515, G945000790

OpenAlex ID: W2108895352

FWCI: 1.305

Cites: 35

Cited by: 12

Related to: 10